Dublin, Jan. 18, 2019 (GLOBE NEWSWIRE) -- The "Nicotine Addiction R&D Pipeline Analysis Report, H2-2018" report has been added to ResearchAndMarkets.com's offering.
The Nicotine Addiction pipeline guide presents complete overview of drugs currently being developed for Nicotine Addiction. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Nicotine Addiction pipeline candidate.
Research and Development progress along with latest news related to each of the Nicotine Addiction pipeline candidates is included.
Major companies participating in therapeutic development of Nicotine Addiction are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.
Amid strong interest for cure of Nicotine Addiction from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Nicotine Addiction clinical and pre clinical products.
The report assists in identifying potential upcoming companies and drugs in Nicotine Addiction pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
Scope of Nicotine Addiction pipeline report includes
- Panorama of Nicotine Addiction pipeline markets including statistics on therapeutic drugs and companies involved
- Nicotine Addiction Pipeline candidates across various development phases including both pre clinical, discovery and clinical stages are covered
- Nicotine Addiction pipeline candidates across various Mechanism of Actions' are also presented in the study
- Overview of companies participating in Nicotine Addiction pipeline with short introduction to their businesses and pipeline projects
- For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co developer and licensee are provided.
- Research and Development progress and trial details, results wherever available, are also included in the pipeline study
- The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Nicotine Addiction pipeline therapeutics
Key Topics Covered:
I. Key Findings
1. Companies Investing in Nicotine Addiction Pipeline include
Number of Companies with Nicotine Addiction projects in pre clinical Development
Number of Companies with Nicotine Addiction projects in Clinical Development
Nicotine Addiction Pipeline Companies based in Americas
Nicotine Addiction Pipeline Companies based in Europe
Nicotine Addiction Pipeline Companies based in Asia Pacific
Nicotine Addiction Pipeline Companies based in Rest of the World
2. Pipeline Candidates include
Nicotine Addiction Pipeline Agents in pre clinical/ Discovery stage of Development
Nicotine Addiction Pipeline Agents in Clinical Development stage
Nicotine Addiction Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs
Small molecules among the Nicotine Addiction Pipeline agents
II. Insights into Nicotine Addiction Pipeline -
1. Disease Overview
Introduction to Nicotine Addiction
Symptoms and Causes of Nicotine Addiction
Treatment or Prevention Options for Nicotine Addiction
Other Details
2. Phase wise Pipeline Compounds
Nicotine Addiction Pipeline Pre Clinical/ Discovery stage Drugs
Nicotine Addiction Pipeline Phase 1 stage Drugs
Nicotine Addiction Pipeline Phase 2 stage Drugs
Nicotine Addiction Pipeline Phase 3 stage Drugs
Nicotine Addiction Pipeline Pre Registration stage Drugs
3. Company wise Nicotine Addiction Pipeline Compounds
4. Nicotine Addiction Pipeline by Mechanism of Action
III. Nicotine Addiction Pipeline Compound Details
Drug Details
1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details
IV. Nicotine Addiction Pipeline Company Briefs
V. Latest News and Developments in Global Nicotine Addiction Pipeline Market
VI. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/6bvgxj/nicotine?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.